Drug discovery

Explore the properties, applications, and handling of Recombinant Human HTR2B Protein (rp370104) for GPCR and serotonin receptor research. Available from Aladdin Scientific.

Get answers to key questions about 4-(4-Fluorophenyl)piperazine-1-carboxamide (F1297738): properties, storage, solubility, and research applications.

Learn about 4-(4-Fluorophenyl)piperazine-1-carboxamide: structure, physicochemical properties, medicinal chemistry applications, and sourcing from Aladdin Scientific.

Explore the structure, properties, and synthetic applications of cis-1-Methylhexahydropyrrolo[3,4-b]pyrrole (C733817) from Aladdin Scientific.

Step-by-step protocol for handling, storing, and applying 5-(Chloromethyl)-3-(pyridin-4-yl)-1,2,4-oxadiazole in synthesis. Safety tips and FAQs included.

Learn about 7-Bromoimidazo[1,2-a]pyridine-3-carbaldehyde (B734852): structure, reactivity, handling, storage, and applications in medicinal chemistry synthesis.

Answers to common questions about 6,8-Dichloroimidazo[1,2-a]pyrazine: structure, purity, storage, solubility, and synthetic use. Shop SKU D735099 at Aladdin.

Explore Zanapezil free base (Z696286): chemical properties, cholinesterase inhibition mechanism, and applications in neuroscience and drug discovery research.

DSM265 is a selective Plasmodium DHODH inhibitor for malaria research. Learn about its mechanism, selectivity, efficacy, and how to order from Aladdin Scientific.

Answers to key questions about DSM265, a selective Plasmodium DHODH inhibitor. Learn about its mechanism, selectivity, applications, and how to order from Aladdin Scientific.

Explore the structure, properties, and medicinal chemistry applications of Methyl [1,2,4]triazolo[1,5-a]pyridine-6-carboxylate (M726203) from Aladdin Scientific.

Explore the chemical properties, handling, and research applications of (1-Phenylcyclopropyl)methylamine Hydrochloride (M730119) from Aladdin Scientific.

Explore key properties, synthesis context, and research applications of 1-(4-fluorophenyl)pyrazole, a fluorinated N-arylpyrazole building block for drug discovery.

Explore the structure, physicochemical properties, synthesis, and research applications of 2-oxa-7-azaspiro[4.4]nonane, a versatile spirocyclic building block.

Explore the chemical properties, synthesis routes, and research applications of 1-methylpyrrolidin-3-amine, a versatile chiral building block for drug discovery.

Step-by-step protocol for handling, dissolving, and applying (3-Phenyl-1,2,4-oxadiazol-5-yl)methanamine in medicinal chemistry and drug discovery research.

Explore the chemical properties, synthesis utility, and research applications of 7-bromo-3H-imidazo[4,5-b]pyridine, a key heterocyclic building block for drug discovery.

Explore the chemical properties, synthesis utility, and research applications of 1-Cyclopentyl-4-aminopiperidine, a versatile piperidine building block for drug discovery.

Explore the properties, synthesis utility, and research applications of 3-Boc-3,9-Diazaspiro[5.5]undecane hydrochloride, a versatile spirocyclic building block.

Explore the properties, synthesis utility, and safety profile of 5-chloro-3-methyl-4-nitro-1H-pyrazole, a versatile heterocyclic building block for drug discovery.

In drug discovery, chemical biology, and organic optoelectronic materials development, rework is often not caused by the “core function” failing. More commonly, it stems from insufficient stability and controllability of the results: along the same route and within the same structural ...

In drug discovery, agrochemical development, and industrial formulations, one of the most frequent reasons for rework is: the activity is there, but the compound is not sufficiently “usable.”

In drug discovery, catalysis, and materials chemistry, quinoline and isoquinoline are often treated as “pretty similar N-heteroaromatics.” But in real experiments, the differences most likely to trigger rework often come from one key factor: the position of the ring nitrogen.

7-membered N-heterocycles—as a structural module—are often used because.

In drug discovery, many molecules end up stuck in the same awkward spot: potency is good, but exposure is insufficient; selectivity looks fine, but metabolism is too fast; in vitro is beautiful, yet in vivo distribution is disappointing. In those moments, you usually don’t want to rebuild the ...

Although target-based drug discovery is currently the dominant approach to drug discovery and development, the latest comprehensive assessment shows that its results are not as good as they could be. The number of drugs discovered by this approach is relatively small, and their therapeutic ...